Genocea Biosciences (GNCA) Tops Q3 EPS by 7c

Genocea Biosciences (NASDAQ: GNCA) reported Q3 EPS of ($0.37), $0.07 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens as Pivotal Trial Advances
• Walmart (WMT) PT Lowered to $115 at Wolfe Research